Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haider Ali

Showing results (351-360 of 457) with videos related to

Pageof 46
Sort By:
Inflammopharmacology|September 10, 2025
Targeting NLRP3 inflammasome with curcumin: mechanisms and therapeutic promise in chronic inflammationSurya Nath Pandey, M Arockia Babu, Kavita Goyal, et al.
Pathology, Research and Practice|December 21, 2024
Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editingAshok Kumar Balaraman, M Arockia Babu, Ehssan Moglad, et al.
Regenerative Therapy|March 4, 2025
Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cellsAshok Kumar Balaraman, M Arockia Babu, Muhammad Afzal, et al.
Journal of Complementary & Integrative Medicine|February 27, 2025
Exploring the therapeutic promise of fisetin: molecular mechanisms and clinical aspects in lung cancerKavita Goyal, M Arockia Babu, Muhammad Afzal, et al.
Biogerontology|January 20, 2025
Targeting senescence and GATA4 in age-related cardiovascular disease: a comprehensive approachMohd Imran, Abdulmalik S A Altamimi, Muhammad Afzal, et al.
Pathology, Research and Practice|July 10, 2024
Harnessing pyroptosis for lung cancer therapy: The impact of NLRP3 inflammasome activationRajiv Dahiya, Vijaykumar B Sutariya, Sheeba Varghese Gupta, et al.
Pathology, Research and Practice|December 1, 2024
Reprogramming tumor-associated macrophages: The role of MEK-STAT3 inhibition in lung cancerSushama Rawat, Ehssan Moglad, Muhammad Afzal, et al.
Frontiers in Immunology|December 8, 2025
Targeting cancer via macrophage-derived exosomal miRNAs: implications for tumor progression and resistancePrasanna Srinivasan Ramalingam, Muhammad Afzal, M Arockia Babu, et al.
Current Neuropharmacology|June 12, 2026
Regulatory Networks of ncRNAs and NF-κB in Glioblastoma: Implications for TherapeuticsMd Sadique Hussain, M Arockia Babu, Rangaswamy Roopashree, et al.
Current Cardiology Reports|May 24, 2023
Sensitivity and Specificity of Wearables for Atrial Fibrillation in Elderly Populations: A Systematic ReviewFaiza Babar, Abdul Manan Cheema, Zubair Ahmad, et al.
Pageof 46

Showing results (351-360 of 457) with videos related to

Sort By:
Pageof 46
Inflammopharmacology|September 10, 2025
Targeting NLRP3 inflammasome with curcumin: mechanisms and therapeutic promise in chronic inflammationSurya Nath Pandey, M Arockia Babu, Kavita Goyal, et al.
Pathology, Research and Practice|December 21, 2024
Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editingAshok Kumar Balaraman, M Arockia Babu, Ehssan Moglad, et al.
Regenerative Therapy|March 4, 2025
Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cellsAshok Kumar Balaraman, M Arockia Babu, Muhammad Afzal, et al.
Journal of Complementary & Integrative Medicine|February 27, 2025
Exploring the therapeutic promise of fisetin: molecular mechanisms and clinical aspects in lung cancerKavita Goyal, M Arockia Babu, Muhammad Afzal, et al.
Biogerontology|January 20, 2025
Targeting senescence and GATA4 in age-related cardiovascular disease: a comprehensive approachMohd Imran, Abdulmalik S A Altamimi, Muhammad Afzal, et al.
Pathology, Research and Practice|July 10, 2024
Harnessing pyroptosis for lung cancer therapy: The impact of NLRP3 inflammasome activationRajiv Dahiya, Vijaykumar B Sutariya, Sheeba Varghese Gupta, et al.
Pathology, Research and Practice|December 1, 2024
Reprogramming tumor-associated macrophages: The role of MEK-STAT3 inhibition in lung cancerSushama Rawat, Ehssan Moglad, Muhammad Afzal, et al.
Frontiers in Immunology|December 8, 2025
Targeting cancer via macrophage-derived exosomal miRNAs: implications for tumor progression and resistancePrasanna Srinivasan Ramalingam, Muhammad Afzal, M Arockia Babu, et al.
Current Neuropharmacology|June 12, 2026
Regulatory Networks of ncRNAs and NF-κB in Glioblastoma: Implications for TherapeuticsMd Sadique Hussain, M Arockia Babu, Rangaswamy Roopashree, et al.
Current Cardiology Reports|May 24, 2023
Sensitivity and Specificity of Wearables for Atrial Fibrillation in Elderly Populations: A Systematic ReviewFaiza Babar, Abdul Manan Cheema, Zubair Ahmad, et al.
Pageof 46